Showing results (2051-2060 of 3,615) with videos related to
Sort By:
Pageof 362
Journal of Viral Hepatitis|November 25, 2003
Occult hepatitis C virus infection in type II mixed cryoglobulinaemiaM Casato, D Lilli, G Donato, et al.Journal of Viral Hepatitis|November 25, 2003
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trialH Van Vlierberghe, G Leroux-Roels, M Adler, et al.Journal of Viral Hepatitis|November 25, 2003
Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapyD L Sylvestre, A R Disston, D P BuiJournal of Viral Hepatitis|July 6, 2019
Genetic diversity of genotype 6 HCV infections in France: Epidemiology and consequences for treatment strategyCharlotte Pronier, Hélène Fontaine, Céline Dorival, et al.Journal of Viral Hepatitis|July 7, 2019
Evaluation of 8-week glecaprevir/pibrentasvir treatment in direct-acting antiviral-naïve noncirrhotic HCV genotype 1 and 2infected patients in a real-world setting in JapanHiroki Ikeda, Tsunamasa Watanabe, Masanori Atsukawa, et al.Journal of Viral Hepatitis|October 10, 2019
Hepatitis C virus eradication with direct-acting antiviral improves insulin resistanceFrancesco Paolo Russo, Alberto Zanetto, Martina Gambato, et al.Journal of Viral Hepatitis|April 12, 2019
Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antiviralsNobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, et al.Journal of Viral Hepatitis|April 12, 2019
Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis BLai Wei, Vedran Pavlovic, Aruna T Bansal, et al.Journal of Viral Hepatitis|May 16, 2017
The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experienceR Bielen, C Moreno, H Van Vlierberghe, et al.Journal of Viral Hepatitis|May 13, 2017
Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic responseG-A Kim, S Han, H-D Kim, et al.Pageof 362